Great West Life Assurance CO Abbott Laboratories Transaction History

Great West Life Assurance CO

$49.6 Billion
Q1 2024

A detailed history of Great West Life Assurance CO transactions in Abbott Laboratories stock. As of the latest transaction made, Great West Life Assurance CO holds 1,166,660 shares of ABT stock, worth $121 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

1,166,660

Previous 1,511,184 22.8%

Holding current value

$121 Million

Previous $166 Million 19.89%

% of portfolio

0.27%

Previous 0.36%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $37.7 Million - $41.7 Million	-344,524 Reduced 22.8%	1,166,660 $133 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $13.5 Million - $16.5 Million	149,536 Added 10.98%	1,511,184 $166 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $294,614 - $353,488	-3,084 Reduced 0.23%	1,361,648 $132 Million
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $2.56 Million - $2.85 Million	-25,414 Reduced 1.83%	1,364,732 $150 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $1.19 Million - $1.4 Million	12,295 Added 0.89%	1,390,146 $141 Million

Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $1.25 Million - $1.47 Million	13,163 Added 0.96%	1,377,851 $152 Million
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $132 Million - $153 Million	1,364,688 New	1,364,688 $132 Million
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $224,656 - $271,537	-2,201 Reduced 0.16%	1,406,511 $153 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $3.55 Million - $4.33 Million	-31,154 Reduced 2.16%	1,408,712 $176 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $6.77 Million - $8.29 Million	58,593 Added 4.24%	1,439,866 $202 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $3.72 Million - $4.12 Million	-31,905 Reduced 2.26%	1,381,273 $164 Million
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $8.33 Million - $9.8 Million	-78,733 Reduced 5.28%	1,413,178 $164 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $3.06 Million - $3.61 Million	-28,154 Reduced 1.85%	1,491,911 $178 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $1.93 Million - $2.1 Million	18,385 Added 1.22%	1,520,065 $166 Million
Q3 2020 Nov 17, 2020	SELL	$91.64 - $111.29 $2.54 Million - $3.08 Million	-27,684 Reduced 1.81%	1,501,680 $163 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $2.05 Million - $2.48 Million	22,322 Added 1.48%	1,529,364 $166 Million
Q2 2020 Aug 17, 2020	SELL	$76.57 - $98.0 $4.76 Million - $6.09 Million	-62,146 Reduced 3.96%	1,507,042 $137 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $3.12 Million - $4.57 Million	-49,721 Reduced 3.07%	1,569,188 $125 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $3.85 Million - $4.29 Million	49,052 Added 3.12%	1,618,909 $141 Million
Q3 2019 Oct 25, 2019	SELL	$81.84 - $88.74 $3.34 Million - $3.62 Million	-40,751 Reduced 2.53%	1,569,857 $131 Million
Q2 2019 Jul 31, 2019	BUY	$72.88 - $85.0 $117 Million - $137 Million	1,610,608 New	1,610,608 $0
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $87.7 Million - $106 Million	-1,323,648 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $1.02 Million - $1.15 Million	-15,500 Reduced 1.16%	1,323,648 $91.9 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $12.1 Million - $14.6 Million	-198,491 Reduced 12.91%	1,339,148 $98.3 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $2.84 Million - $3.13 Million	-49,292 Reduced 3.11%	1,537,639 $93.9 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $4.53 Million - $5.12 Million	-80,458 Reduced 4.83%	1,586,931 $95.2 Million
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $20.2 Million - $21.7 Million	-377,167 Reduced 18.45%	1,667,389 $95.1 Million
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $98.3 Million - $110 Million	2,044,556	2,044,556 $109 Million

Others Institutions Holding ABT

# of Institutions

3,130

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Abbott Laboratories Transaction History